- 期刊
Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine Booster in Taiwanese Toddlers
並列摘要
Background/Purpose: Pneumococcal infection causes high morbidity and mortality in children. Prevention of pneumococcal diseases by effective vaccination is an urgent need. This study evaluated the safety and immunogenicity of heptavalent pneumococcal conjugate (7VPnC) vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) booster dose administered at 15-20 months of age in Taiwanese toddlers. Methods: Fifty-eight healthy Taiwanese toddlers who were primed with three doses of the 7VPnC vaccine in infancy received a booster dose in an open-label, noncomparative trial. Routine oral polio vaccine and diphtheria toxoid, tetanus toxoid, and pertussis vaccine were administered concomitantly. Surveillance for safety was conducted after vaccination. Antibody concentration to each of the seven pneumococcal serotypes was measured before and 1 month after the booster dose. Results: Mild to moderate local reactions were common (45-50%). Fever, fussiness, restlessness, and loss of appetite were the most frequent systemic reactions (31-50%). Before the booster dose of vaccine, 68% (for serotype 18C) to 100% (for serotype 14) of subjects had antibody concentrations ≥0.2μg/mL to different pneumococcal serotypes. After the booster dose, the geometric mean concentration of IgG increased significantly (p＜0.001) for all seven serotypes indicating the induction of immunologic memories. Ninety-eight percent of the toddlers had antibody concentration ≥0.2μg/mL against all serotypes after the booster. Conclusion: The 7VPnC vaccine containing the prevalent serotypes in Taiwan is safe and effective in boosting immunity against pneumococcal disease in Taiwanese children.
延伸閱讀
- 陳金樹、葛應欽（1985）。Epidemiological Aspects of Hepatitis B Viral Infection in Preschool Children and Their Parents in a Community of Southern Taiwan。The Kaohsiung Journal of Medical Sciences，1(4)，240-251。https://doi.org/10.6452/KJMS.198504.0240
- 詹蕙嘉、杜慧珍、吳庭妮、朱廣中、王德原、施養志（2013）。Post-Market Surveillance of Pneumococcal Polysaccharide Conjugate Vaccine in Taiwan。食品藥物研究年報，(4)，171-178。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201311-201409230017-201409230017-171-178
- Huang, Y. C., Ho, Y. H., Hsieh, Y. C., Lin, H. C., Hwang, K. P., Chang, L. Y., & Huang, L. M. (2008). A 6-year Retrospective Epidemiologic Study of Pediatric Pneumococcal Pneumonia in Taiwan. Journal of the Formosan Medical Association, 107(12), s945-s951. https://www.airitilibrary.com/Article/Detail?DocID=09296646-200812-107-12-s945-s951-a
- Lai, C. C., Lee, L. N., Yu, C. J., Hsueh, P. R., Yang, P. C., Kuo, S. H., & Luh, K. T. (2007). Antibody Responses to Pneumococcal Polysaccharide Vaccine in Taiwanese Patients with Chronic Obstructive Pulmonary Disease. Journal of the Formosan Medical Association, 106(3), 196-203. https://doi.org/10.29828/JFMA.200703.0015
- 劉定萍（2016）。Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201610203